30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Elite Pharmaceuticals Inc (ELPT)

Track

Stock chart
Ticker: ELPT
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Plassche Douglas
EVP Operations
1 sale — total 499,200 USD
Sale 2 Oct 2025
Value US$2,606,306.82 | Price 287.48 | Shares 76,121
Sale 22 Aug 2025
Value US$4,075,820.11 | Price 304.58 | Shares 60,063
Proposed sale 22 Aug 2025
Value US$555,000.00 | Price 5.55 | Shares 100,000
Buy 10 Jul 2025
Value US$9,639.57 | Price 0.59 | Shares 16,366
Sale 8 Jul 2025
Value US$115,800.00 | Price 0.58 | Shares 200,000
Proposed sale 8 Jul 2025
Value US$303,000.00 | Price 0.61 | Shares 500,000
Sale 24 Oct 2024
Value US$170,305.32 | Price 0.51 | Shares 333,932
Sale 23 Oct 2024
Value US$392,000.00 | Price 0.49 | Shares 800,000
Proposed sale 23 Oct 2024
Value US$680,359.20 | Price 0.60 | Shares 1,133,932
Sale 18 Mar 2016
Value US$88,266.78 | Price 0.34 | Shares 258,090
Sale 17 Mar 2016
Value US$107,788.35 | Price 0.35 | Shares 312,430
Sale 24 Feb 2016
Value US$31,141.36 | Price 0.31 | Shares 100,456
Sale 22 Feb 2016
Value US$32,090.00 | Price 0.32 | Shares 100,000
Sale 17 Feb 2016
Value US$15,580.00 | Price 0.31 | Shares 50,000
Sale 5 Feb 2016
Value US$8,052.00 | Price 0.33 | Shares 24,400
Sale 4 Feb 2016
Value US$111,891.20 | Price 0.32 | Shares 349,660
Sale 3 Feb 2016
Value US$15,020.94 | Price 0.33 | Shares 45,518
Sale 2 Feb 2016
Value US$4,290.00 | Price 0.33 | Shares 13,000
Sale 1 Feb 2016
Value US$106,182.00 | Price 0.34 | Shares 312,300
Sale 29 Jan 2016
Value US$40,250.00 | Price 0.35 | Shares 115,000
Sale 18 Nov 2015
Value US$7,625.00 | Price 0.31 | Shares 25,000
Sale 17 Nov 2015
Value US$7,502.50 | Price 0.30 | Shares 25,000
Sale 16 Nov 2015
Value US$15,125.00 | Price 0.30 | Shares 50,000
Sale 13 Nov 2015
Value US$15,000.00 | Price 0.30 | Shares 50,000
Sale 27 Apr 2015
Value US$20,167.97 | Price 0.24 | Shares 85,530
Buy 26 Sep 2014
Value US$82,384.65 | Price 0.31 | Shares 265,500
Buy 25 Sep 2014
Value US$133,956.35 | Price 0.31 | Shares 434,500
Sale 9 May 2014
Value US$125,943.77 | Price 0.38 | Shares 329,437
Sale 2 Apr 2014
Value US$60,542.24 | Price 0.41 | Shares 147,664
Sale 27 Mar 2014
Value US$81,165.41 | Price 0.43 | Shares 190,172
Sale 11 Mar 2014
Value US$144,003.19 | Price 0.60 | Shares 239,367
Sale 11 Mar 2014
Value US$144,003.19 | Price 0.60 | Shares 239,367
Sale 11 Mar 2014
Value US$144,003.19 | Price 0.60 | Shares 239,367
Sale 11 Mar 2014
Value US$144,003.19 | Price 0.60 | Shares 239,367
Sale 7 Mar 2014
Value US$714,986.00 | Price 0.68 | Shares 1,051,450
Sale 7 Mar 2014
Value US$714,986.00 | Price 0.68 | Shares 1,051,450
Sale 7 Mar 2014
Value US$714,986.00 | Price 0.68 | Shares 1,051,450
Sale 7 Mar 2014
Value US$714,986.00 | Price 0.68 | Shares 1,051,450
Sale 6 Mar 2014
Value US$692,343.58 | Price 0.90 | Shares 773,050
Sale 6 Mar 2014
Value US$692,343.58 | Price 0.90 | Shares 773,050
Sale 6 Mar 2014
Value US$692,343.58 | Price 0.90 | Shares 773,050
Sale 6 Mar 2014
Value US$692,343.58 | Price 0.90 | Shares 773,050
Sale 13 Jan 2014
Value US$147,421.69 | Price 0.18 | Shares 805,583
Sale 13 Jan 2014
Value US$147,421.69 | Price 0.18 | Shares 805,583
Sale 13 Jan 2014
Value US$147,421.69 | Price 0.18 | Shares 805,583
Sale 13 Jan 2014
Value US$147,413.45 | Price 0.18 | Shares 805,538
Sale 5 Dec 2013
Value US$34,512.50 | Price 0.13 | Shares 275,000
Sale 5 Dec 2013
Value US$34,512.50 | Price 0.13 | Shares 275,000
Sale 5 Dec 2013
Value US$34,512.50 | Price 0.13 | Shares 275,000
Sale 5 Dec 2013
Value US$34,512.50 | Price 0.13 | Shares 275,000
Sale 2 Dec 2013
Value US$12,520.00 | Price 0.13 | Shares 100,000
Sale 2 Dec 2013
Value US$12,520.00 | Price 0.13 | Shares 100,000
Sale 2 Dec 2013
Value US$12,520.00 | Price 0.13 | Shares 100,000
Sale 27 Nov 2013
Value US$3,030.00 | Price 0.12 | Shares 25,000
Sale 27 Nov 2013
Value US$3,030.00 | Price 0.12 | Shares 25,000
Sale 27 Nov 2013
Value US$3,030.00 | Price 0.12 | Shares 25,000
Sale 27 Nov 2013
Value US$3,030.00 | Price 0.12 | Shares 25,000
Sale 26 Nov 2013
Value US$2,792.59 | Price 0.12 | Shares 23,626
Sale 26 Nov 2013
Value US$43,125.60 | Price 0.12 | Shares 357,000
Sale 26 Nov 2013
Value US$2,792.59 | Price 0.12 | Shares 23,626
Sale 26 Nov 2013
Value US$43,125.60 | Price 0.12 | Shares 357,000
Sale 26 Nov 2013
Value US$2,792.59 | Price 0.12 | Shares 23,626
Sale 26 Nov 2013
Value US$43,125.60 | Price 0.12 | Shares 357,000
Sale 26 Nov 2013
Value US$2,792.59 | Price 0.12 | Shares 23,626
Sale 26 Nov 2013
Value US$43,125.60 | Price 0.12 | Shares 357,000
Sale 19 Nov 2013
Value US$2,457.00 | Price 0.12 | Shares 21,000
Sale 19 Nov 2013
Value US$2,499.00 | Price 0.12 | Shares 21,000
Sale 19 Nov 2013
Value US$2,457.00 | Price 0.12 | Shares 21,000
Sale 19 Nov 2013
Value US$2,457.00 | Price 0.12 | Shares 21,000
Sale 18 Nov 2013
Value US$137,475.00 | Price 0.12 | Shares 1,170,000
Sale 18 Nov 2013
Value US$137,475.00 | Price 0.12 | Shares 1,170,000
Sale 18 Nov 2013
Value US$137,475.00 | Price 0.12 | Shares 1,170,000
Sale 18 Nov 2013
Value US$137,475.00 | Price 0.12 | Shares 1,170,000
Sale 15 Nov 2013
Value US$37,307.26 | Price 0.12 | Shares 318,050
Sale 15 Nov 2013
Value US$37,307.26 | Price 0.12 | Shares 318,050
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-03 2025-10-02 S Sale
Plassche Douglas

EVP Operations

Officer
76,121 +19.4%
287.48
US$2,606,307 		76,121 +19.4% 287.48 US$2,606,307
2025-08-26 2025-08-22 S Sale
ELITE PHARMACEUTICALS INC /NV/

EVP Operations

Officer
60,063 -39.2%
304.58
US$4,075,820 		60,063 -39.2% 304.58 US$4,075,820
2025-08-22 2025-08-22 PrS Proposed sale
Plassche Douglas

Officer

Officer
74,884
52.22
US$4,500,875 		74,884 52.22 US$4,500,875
2025-07-25 2025-07-10 B Purchase
Kirkov Kirko

Chief Commercial Officer

Officer
16,366 +inf%
0.59
US$9,640 		16,366 +inf% 0.59 US$9,640
2025-07-10 2025-07-08 S Sale
Plassche Douglas

EVP Operations

Officer
200,000 -8.0%
0.58
US$115,800 		200,000 -8.0% 0.58 US$115,800
2025-07-08 2025-07-08 PrS Proposed sale
Plassche Douglas

Officer

Officer
500,000
0.61
US$303,000 		500,000 0.61 US$303,000
2024-10-28 2024-10-24 S Sale
Plassche Douglas

SVP of Operations

Officer
333,932 -100.0%
0.51
US$170,305 		333,932 -100.0% 0.51 US$170,305
2024-10-28 2024-10-23 S Sale
Plassche Douglas

SVP of Operations

Officer
800,000 -70.6%
0.49
US$392,000 		800,000 -70.6% 0.49 US$392,000
2024-10-23 2024-10-23 PrS Proposed sale
Plassche Douglas

Officer

Officer
1,133,932
0.60
US$680,359 		1,133,932 0.60 US$680,359
2016-03-21 2016-03-18 S Sale TREPPEL JERRY

former Chairman
258,090 -3.3%
0.34
US$88,267 		258,090 -3.3% 0.34 US$88,267
2016-03-21 2016-03-17 S Sale TREPPEL JERRY

former Chairman
312,430 -3.8%
0.35
US$107,788 		312,430 -3.8% 0.35 US$107,788
2016-02-24 2016-02-24 S Sale TREPPEL JERRY

former Chairman
100,456 -1.2%
0.31
US$31,141 		100,456 -1.2% 0.31 US$31,141
2016-02-24 2016-02-22 S Sale TREPPEL JERRY

former Chairman
100,000 -1.2%
0.32
US$32,090 		100,000 -1.2% 0.32 US$32,090
2016-02-18 2016-02-17 S Sale TREPPEL JERRY

former Chairman
50,000 -0.6%
0.31
US$15,580 		50,000 -0.6% 0.31 US$15,580
2016-02-18 2016-02-05 S Sale TREPPEL JERRY

former Chairman
24,400 -0.3%
0.33
US$8,052 		24,400 -0.3% 0.33 US$8,052
2016-02-18 2016-02-04 S Sale TREPPEL JERRY

former Chairman
349,660 -4.0%
0.32
US$111,891 		349,660 -4.0% 0.32 US$111,891
2016-02-18 2016-02-03 S Sale TREPPEL JERRY

former Chairman
45,518 -0.5%
0.33
US$15,021 		45,518 -0.5% 0.33 US$15,021
2016-02-18 2016-02-02 S Sale TREPPEL JERRY

former Chairman
13,000 -0.1%
0.33
US$4,290 		13,000 -0.1% 0.33 US$4,290
2016-02-18 2016-02-01 S Sale TREPPEL JERRY

former Chairman
312,300 -3.4%
0.34
US$106,182 		312,300 -3.4% 0.34 US$106,182
2016-02-18 2016-01-29 S Sale TREPPEL JERRY

former Chairman
115,000 -1.3%
0.35
US$40,250 		115,000 -1.3% 0.35 US$40,250
2015-11-18 2015-11-18 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
25,000 -0.3%
0.31
US$7,625 		25,000 -0.3% 0.31 US$7,625
2015-11-18 2015-11-17 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
25,000 -0.3%
0.30
US$7,502 		25,000 -0.3% 0.30 US$7,502
2015-11-18 2015-11-16 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
50,000 -0.5%
0.30
US$15,125 		50,000 -0.5% 0.30 US$15,125
2015-11-18 2015-11-13 S Sale TREPPEL JERRY

Chairman of Board

Executive Director
50,000 -0.5%
0.30
US$15,000 		50,000 -0.5% 0.30 US$15,000
2015-04-28 2015-04-27 S Sale Plassche Douglas

Executive VP of Operations

Officer
85,530 -53.9%
0.24
US$20,168 		85,530 -53.9% 0.24 US$20,168
2014-09-29 2014-09-26 B Purchase Hakim Nasrat A

CEO & President

Executive Director
265,500 +10.9%
0.31
US$82,385 		265,500 +10.9% 0.31 US$82,385
2014-09-29 2014-09-25 B Purchase Hakim Nasrat A

CEO & President

Executive Director
434,500 +21.7%
0.31
US$133,956 		434,500 +21.7% 0.31 US$133,956
2014-05-13 2014-05-09 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
329,437 -5.6%
0.38
US$125,944 		329,437 -5.6% 0.38 US$125,944
2014-04-04 2014-04-02 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
147,664 -2.5%
0.41
US$60,542 		147,664 -2.5% 0.41 US$60,542
2014-03-31 2014-03-27 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
190,172 -3.1%
0.43
US$81,165 		190,172 -3.1% 0.43 US$81,165
2014-03-17 2014-03-11 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
239,367 -1.2%
0.60
US$144,003 		239,367 -1.2% 0.60 US$144,003
2014-03-17 2014-03-11 S Sale EPIC PHARMA LLC Large shareholder
239,367 -0.4%
0.60
US$144,003 		239,367 -0.4% 0.60 US$144,003
2014-03-17 2014-03-11 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
239,367 -1.6%
0.60
US$144,003 		239,367 -1.6% 0.60 US$144,003
2014-03-17 2014-03-11 S Sale EPIC INVESTMENTS, LLC Large shareholder
239,367 -0.4%
0.60
US$144,003 		239,367 -0.4% 0.60 US$144,003
2014-03-10 2014-03-07 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
1,051,450 -6.6%
0.68
US$714,986 		1,051,450 -6.6% 0.68 US$714,986
2014-03-10 2014-03-07 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
1,051,450 -4.9%
0.68
US$714,986 		1,051,450 -4.9% 0.68 US$714,986
2014-03-10 2014-03-07 S Sale EPIC INVESTMENTS, LLC Large shareholder
1,051,450 -1.5%
0.68
US$714,986 		1,051,450 -1.5% 0.68 US$714,986
2014-03-10 2014-03-07 S Sale EPIC PHARMA LLC Large shareholder
1,051,450 -1.5%
0.68
US$714,986 		1,051,450 -1.5% 0.68 US$714,986
2014-03-10 2014-03-06 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
773,050 -4.8%
0.90
US$692,344 		773,050 -4.8% 0.90 US$692,344
2014-03-10 2014-03-06 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
773,050 -3.6%
0.90
US$692,344 		773,050 -3.6% 0.90 US$692,344
2014-03-10 2014-03-06 S Sale EPIC INVESTMENTS, LLC Large shareholder
773,050 -1.1%
0.90
US$692,344 		773,050 -1.1% 0.90 US$692,344
2014-03-10 2014-03-06 S Sale EPIC PHARMA LLC Large shareholder
773,050 -1.1%
0.90
US$692,344 		773,050 -1.1% 0.90 US$692,344
2014-01-17 2014-01-13 S Sale EPIC PHARMA LLC Large shareholder
805,583 -1.1%
0.18
US$147,422 		805,583 -1.1% 0.18 US$147,422
2014-01-17 2014-01-13 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
805,583 -5.0%
0.18
US$147,422 		805,583 -5.0% 0.18 US$147,422
2014-01-17 2014-01-13 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
805,583 -3.7%
0.18
US$147,422 		805,583 -3.7% 0.18 US$147,422
2014-01-17 2014-01-13 S Sale EPIC INVESTMENTS, LLC Large shareholder
805,538 -1.1%
0.18
US$147,413 		805,538 -1.1% 0.18 US$147,413
2013-12-16 2013-12-05 S Sale EPIC INVESTMENTS, LLC Large shareholder
275,000 -0.4%
0.13
US$34,512 		275,000 -0.4% 0.13 US$34,512
2013-12-13 2013-12-05 S Sale EPIC PHARMA LLC Large shareholder
275,000 -0.4%
0.13
US$34,512 		275,000 -0.4% 0.13 US$34,512
2013-12-13 2013-12-05 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
275,000 -1.7%
0.13
US$34,512 		275,000 -1.7% 0.13 US$34,512
2013-12-13 2013-12-05 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
275,000 -1.3%
0.13
US$34,512 		275,000 -1.3% 0.13 US$34,512
2013-12-04 2013-12-02 S Sale EPIC PHARMA LLC Large shareholder
100,000 -0.1%
0.13
US$12,520 		100,000 -0.1% 0.13 US$12,520
2013-12-04 2013-12-02 S Sale EPIC INVESTMENTS, LLC Large shareholder
100,000 -0.1%
0.13
US$12,520 		100,000 -0.1% 0.13 US$12,520
2013-12-04 2013-12-02 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
100,000 -0.5%
0.13
US$12,520 		100,000 -0.5% 0.13 US$12,520
2013-11-29 2013-11-27 S Sale EPIC INVESTMENTS, LLC Large shareholder
25,000 -0.0%
0.12
US$3,030 		25,000 -0.0% 0.12 US$3,030
2013-11-29 2013-11-27 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
25,000 -0.1%
0.12
US$3,030 		25,000 -0.1% 0.12 US$3,030
2013-11-29 2013-11-27 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
25,000 -0.2%
0.12
US$3,030 		25,000 -0.2% 0.12 US$3,030
2013-11-29 2013-11-27 S Sale EPIC PHARMA LLC Large shareholder
25,000 -0.0%
0.12
US$3,030 		25,000 -0.0% 0.12 US$3,030
2013-12-16 2013-11-26 S Sale EPIC INVESTMENTS, LLC Large shareholder
23,626 -0.0%
0.12
US$2,793 		23,626 -0.0% 0.12 US$2,793
2013-12-13 2013-11-26 S Sale EPIC PHARMA LLC Large shareholder
23,626 -0.0%
0.12
US$2,793 		23,626 -0.0% 0.12 US$2,793
2013-12-13 2013-11-26 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
23,626 -0.2%
0.12
US$2,793 		23,626 -0.2% 0.12 US$2,793
2013-12-13 2013-11-26 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
23,626 -0.1%
0.12
US$2,793 		23,626 -0.1% 0.12 US$2,793
2013-11-29 2013-11-26 S Sale EPIC INVESTMENTS, LLC Large shareholder
357,000 -0.5%
0.12
US$43,126 		357,000 -0.5% 0.12 US$43,126
2013-11-29 2013-11-26 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
357,000 -1.6%
0.12
US$43,126 		357,000 -1.6% 0.12 US$43,126
2013-11-29 2013-11-26 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
357,000 -2.2%
0.12
US$43,126 		357,000 -2.2% 0.12 US$43,126
2013-11-29 2013-11-26 S Sale EPIC PHARMA LLC Large shareholder
357,000 -0.5%
0.12
US$43,126 		357,000 -0.5% 0.12 US$43,126
2013-11-19 2013-11-19 S Sale EPIC INVESTMENTS, LLC Large shareholder
21,000 -0.0%
0.12
US$2,457 		21,000 -0.0% 0.12 US$2,457
2013-11-19 2013-11-19 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
21,000 -0.1%
0.12
US$2,499 		21,000 -0.1% 0.12 US$2,499
2013-11-19 2013-11-19 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
21,000 -0.1%
0.12
US$2,457 		21,000 -0.1% 0.12 US$2,457
2013-11-19 2013-11-19 S Sale EPIC PHARMA LLC Large shareholder
21,000 -0.0%
0.12
US$2,457 		21,000 -0.0% 0.12 US$2,457
2013-11-19 2013-11-18 S Sale EPIC INVESTMENTS, LLC Large shareholder
1,170,000 -1.6%
0.12
US$137,475 		1,170,000 -1.6% 0.12 US$137,475
2013-11-19 2013-11-18 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
1,170,000 -6.9%
0.12
US$137,475 		1,170,000 -6.9% 0.12 US$137,475
2013-11-19 2013-11-18 S Sale NIGALAYE ASHOK G

Chief Scientific Officer

Executive Director Large shareholder
1,170,000 -5.1%
0.12
US$137,475 		1,170,000 -5.1% 0.12 US$137,475
2013-11-19 2013-11-18 S Sale EPIC PHARMA LLC Large shareholder
1,170,000 -1.6%
0.12
US$137,475 		1,170,000 -1.6% 0.12 US$137,475
2013-11-19 2013-11-15 S Sale EPIC INVESTMENTS, LLC Large shareholder
318,050 -0.4%
0.12
US$37,307 		318,050 -0.4% 0.12 US$37,307
2013-11-19 2013-11-15 S Sale NARINE JEENARINE Non-Executive Director Large shareholder
318,050 -1.9%
0.12
US$37,307 		318,050 -1.9% 0.12 US$37,307
Explore more

More insider trading research around Elite Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America